Kristin Muhlner
Chief Executive Officer
Affect Therapeutics
Country or State
United States
Bio
Board member, operations executive, and strategic adviser with multiple successful exits and a passion for growing winning businesses and teams. Specialties: Corporate strategy, financial planning, sales and marketing, product
Similar Speakers
Current Position
Chief Executive Officer at Affect Therapeutics
Degrees
BA, Economics